CRW vs. EMIS, INS, KOO, RENX, COG, INHC, IQAI, FDBK, DVRG, and TRLS
Should you be buying Craneware stock or one of its competitors? The main competitors of Craneware include EMIS Group (EMIS), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), IQ-AI (IQAI), Feedback (FDBK), DeepVerge (DVRG), and Trellus Health (TRLS). These companies are all part of the "health information services" industry.
Craneware vs.
Craneware (LON:CRW) and EMIS Group (LON:EMIS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.
Craneware presently has a consensus price target of GBX 2,700, indicating a potential upside of 32.03%. Given Craneware's stronger consensus rating and higher probable upside, equities research analysts clearly believe Craneware is more favorable than EMIS Group.
EMIS Group has lower revenue, but higher earnings than Craneware. EMIS Group is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.
In the previous week, Craneware had 2 more articles in the media than EMIS Group. MarketBeat recorded 2 mentions for Craneware and 0 mentions for EMIS Group. Craneware's average media sentiment score of 0.76 beat EMIS Group's score of 0.00 indicating that Craneware is being referred to more favorably in the media.
EMIS Group has a net margin of 17.23% compared to Craneware's net margin of 6.18%. EMIS Group's return on equity of 23.17% beat Craneware's return on equity.
EMIS Group received 12 more outperform votes than Craneware when rated by MarketBeat users. Likewise, 75.38% of users gave EMIS Group an outperform vote while only 71.77% of users gave Craneware an outperform vote.
Craneware pays an annual dividend of GBX 29 per share and has a dividend yield of 1.4%. EMIS Group pays an annual dividend of GBX 42 per share. Craneware pays out 11,153.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. EMIS Group pays out 8,936.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Craneware has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500. Comparatively, EMIS Group has a beta of -0.13, indicating that its stock price is 113% less volatile than the S&P 500.
60.2% of Craneware shares are owned by institutional investors. Comparatively, 105.6% of EMIS Group shares are owned by institutional investors. 19.3% of Craneware shares are owned by insiders. Comparatively, 3.6% of EMIS Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Craneware beats EMIS Group on 10 of the 19 factors compared between the two stocks.
Get Craneware News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Craneware Competitors List
Related Companies and Tools
This page (LON:CRW) was last updated on 1/13/2025 by MarketBeat.com Staff
